MedPath
HSA Approval

NEW TONIN TROCHE L

SIN04537P

NEW TONIN TROCHE L

NEW TONIN TROCHE L

May 21, 1990

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderSATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

LOZENGE

ORAL

Medical Information

NA

xna

Manufacturer Information

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL CO LTD

Active Ingredients

NOSCAPINE

60 mg

Noscapine

GLYCYRRHIZA EXTRACT

125 mg

Glycyrrhiza glabra

APRICOT KERNEL EXTRACT

60 mg

Apricot kernel oil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEW TONIN TROCHE L - HSA Approval | MedPath